Pharma Industry Review

Merck KGaA is moving forward with the acquisition of SpringWorks Therapeutics, confirming a definitive agreement at $47 per share in

As we approach the midpoint of the 2020s, the pharmaceutical industry has undergone a radical digital transformation, driven by the

Protecting temperature-sensitive pharmaceutical goods on their journey from manufacturer to end-user is a major global challenge. A SenseAnywhere White Paper

Global biopharmaceutical leader AstraZeneca has officially opened a new $300 million state-of-the-art cell therapy manufacturing facility in Rockville, Maryland, marking

Eli Lilly and Company announced groundbreaking Phase 2 results for its investigational siRNA therapy lepodisiran, which reduced lipoprotein(a) [Lp(a)] levels

Novartis has received its third U.S. Food and Drug Administration (FDA) approval for Fabhalta® (iptacopan), marking a major milestone as

The unique OptoDrum device for automated in vivo assessment of visual performance in mice and rats offers unmatched capabilities for